英基 IMGN 深 沪
已收盘 02-12 16:00:00 美东时间
31.23
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 31.23
- 总市值 77.76亿
- 52周最高 31.25
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.605
- 委 比 0.00%
- 总股本 2.49亿
- 历史最高 31.25
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.51
- 每 手 1
- 风险率 6.97%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Looking At AbbVie's Recent Unusual Options Activity
Investors with a lot of money to spend have taken a bullish stance on AbbVie (N...
12-18 04:01
CytomX Therapeutics to Present at Upcoming December Investor Conferences
CytomX Therapeutics announced that its management will participate in two investor conferences in December 2025: the 8th Annual Evercore Healthcare Conference on December 2 in Coral Gables, FL, and the Piper Sandler 37th Annual Healthcare Conference on December 4 in New York, NY. Both events will feature fireside chats and live webcasts available on CytomX’s website. The company, focused on developing conditionally activated biologics for oncolog...
11-25 13:00
Unpacking the Latest Options Trading Trends in AbbVie
Financial giants have made a conspicuous bearish move on AbbVie. Our analysis o...
11-21 02:01
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
CytomX Therapeutics' CEO, Sean McCarthy, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 20, 2025. A live webcast of the presentation will be available on CytomX's website, and management will also hold one-on-one meetings with registered investors. CytomX is focused on developing conditionally activated biologics for cancer treatment, utilizing its PROBODY® therapeutic platform to create lo...
11-13 13:00
What the Options Market Tells Us About AbbVie
Investors with a lot of money to spend have taken a bullish stance on AbbVie (N...
11-04 01:02
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025
CytomX Therapeutics, a leader in conditionally activated biologics, will announce its third-quarter 2025 financial results on November 6 after U.S. markets close. A conference call and webcast will follow at 5:00 p.m. ET / 2:00 p.m. PT. Access the webcast via CytomX’s website or register beforehand. The company, focused on localized cancer therapies, features a PROBODY platform with candidates like CX-2051 and CX-801. For more info, contact Chris...
10-30 12:00
A Closer Look at AbbVie's Options Market Dynamics
Whales with a lot of money to spend have taken a noticeably bullish stance on A...
10-01 04:01
Decoding AbbVie's Options Activity: What's the Big Picture?
Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE: ABBV). And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
09-27 04:02
石英纤维布专家交流
（来源：老司机驾新车） 1、石英纤维布行业供需现状 供需关系与产能限制：当前石英纤维布行业需求大于供给，尽管近半年市场炒作较热，但实际供给量有限。产能受限主因工...
08-31 21:13
